Exhibits Drive Attendee Action at Interphex 2014
INTERPEHX 2014 attendees tested their driving skills in a racecar simulator at the Federal Equipment booth.
Visitors to INTERPEHX 2014 tested their driving skills in a racecar simulator at the Federal Equipment booth. Pharmaceutical Technology’s publisher, Mike Tracey (pictured) was a participant.
INTERPHEX 2014 attracted 12,000 attendees to more that 650 exhibitors at the Javits Center in New York City on March 18-20. INTERPHEX 2015 will be held April 21-23 in New York.
Federal Equipment has more than 50 years of experience in the processing equipment industry, providing used equipment for solid dose, sterile, API and related pharmaceutical process industries.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
